Back
Nektar Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
54
NKTR
Nektar Therapeutics
Last Price:
$25.15
Seasonality Move:
3.38%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
Nektar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.51 | Sell |
20-day SMA: | 18.11 | Buy |
50-day SMA: | 13.5 | Buy |
200-day SMA: | 14.49 | Buy |
8-day EMA: | 9.12 | Buy |
20-day EMA: | 4.18 | Buy |
50-day EMA: | 1.77 | Buy |
200-day EMA: | 0.46 | Buy |
Nektar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.26 | Buy |
Relative Strength Index (14 RSI): | 63.16 | Buy |
Chaikin Money Flow: | 131313 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.54 - 24.54) | Buy |
Bollinger Bands (100): | (7.63 - 17.43) | Buy |
Nektar Therapeutics Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 23.36 while NKTR 8-day simple moving average is 24.51, which is a Sell signal.
-
The stock price of NKTR is 23.36 while Nektar Therapeutics 20-day SMA is 18.11, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 13.50 while NKTR share price is 23.36, making it a Buy technically.
-
NKTR stock price is 23.36 and Nektar Therapeutics 200-day simple moving average is 14.49, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
54
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a BuyThe current Nektar Therapeutics [NKTR] share price is $23.36. The Score for NKTR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
289.8M
Price in USD:
23.36
Share Volume:
1.3M
Nektar Therapeutics 52-Week Range
52-Week High:
37.38
52-Week Low:
6.48
Buy
54
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 23.36 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 23.36 while NKTR 8-day exponential moving average is 9.12, which is a Buy signal.
-
The stock price of NKTR is 23.36 while Nektar Therapeutics 20-day EMA is 4.18, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 1.77 while NKTR share price is 23.36, making it a Buy technically.
-
NKTR stock price is 23.36 and Nektar Therapeutics 200-day simple moving average is 0.46, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 3.26, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 63.16, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (8.54 - 24.54), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is (7.63 - 17.43), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.